Uganda, April 24 -- Scientists at the Uganda Virus Research Institute (UVRI) have said they are designing an HIV vaccine to address the high burden of the disease.

This information comes about four months after the discontinuation of the clinical trials for an HIV prevention vaccine, which scientists at the UVRI and Medical Research Council (MRC) were spearheading.

The trials were discontinued because an independent monitoring committee found that the vaccine regimens had "little or no chance" of preventing HIV acquisition. The vaccine was not developed in Uganda but was tested in

Uganda, Tanzania and South Africa which are some of the countries with high disease burden.

In an interview yesterday on Tuesday with this newspaper, Prof P...